BioSpace News Archive

BioKansas, the state’s life science trade organization, is proud to announce that its Board of Directors has appointed Sonia Hall, PhD as President & CEO effective immediately.

Castle Biosciences, Inc. (Nasdaq: CSTL), announced today the closing of its previously announced initial public offering of 4,600,000 shares of its common stock, which includes 600,000 shares sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares

Veteran health plan executive brings deep regional experience

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Mylan N.V. in connection with the proposed acquisition of the Company by Pfizer Inc..

FUJIFILM Holdings America Corporation (Fujifilm), today announced the first-ever recipients of the Fujifilm Fellowship at Harvard Medical School (HMS).

Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies, today announced that it has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for OTL-103

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today the publication in Nature Biotechnology of a manuscript by Jeffrey Miller, Ph.D., and colleagues at Sangamo, describing two new strategies for optimizing the specificity of genome editing using zinc finger nucleases (ZFNs)

Foundation to Serve More than 38,000 People Living with Epilepsy in the County

“I wanted to create an effective way to help my mother and other individuals with incontinence,” said an inventor, from Lumpkin, Ga., “so I invented BROWN’S COMFORT.”

A.S. Watson Group announced that it has entered into an exclusive partnership agreement with Prenetics, a leading genetics and digital health company in Asia and Europe